The roles of PIKE in tumorigenesis

Acta Pharmacologica Sinica

Volumn 34, Issue 8, 2013, Pages 991-997

  Qi, Qi ^a   Ye, Keqiang ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Akt; cancer; phosphoinositide 3 kinase; PIKE; tumorigenesis

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; PHOSPHOINOSITIDE 3 KINASE ENHANCER; UNCLASSIFIED DRUG;

APOPTOSIS; CANCER THERAPY; CARCINOGENESIS; CELL MEMBRANE; CELL NUCLEUS; CYTOPLASM; ENZYME ACTIVITY; HUMAN; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTO ONCOGENE; REVIEW; TUMOR GROWTH;

ANIMALS; CARCINOGENESIS; CELL TRANSFORMATION, NEOPLASTIC; GTP-BINDING PROTEINS; GTPASE-ACTIVATING PROTEINS; HUMANS; NEOPLASM INVASIVENESS; PHOSPHATIDYLINOSITOL 3-KINASES;

EID: 84882377016     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2013.71     Document Type: Review

References (90)

1. Jackson TR, Kearns BG, Theibert AB. Cytohesins and centaurins: Mediators of PI 3-kinase-regulated Arf signaling. Trends Biochem Sci 2000; 25: 489-95
2. Ahn JY, Rong R, Kroll TG, Van Meir EG, Snyder SH, Ye K. PIKE (phosphatidylinositol 3-kinase enhancer)-A GTPase stimulates Akt activity and mediates cellular invasion. J Biol Chem 2004; 279: 16441-51 (Pubitemid 38509342)
3. Rong R, Ahn JY, Huang H, Nagata E, Kalman D, Kapp JA, et al. PI3 kinase enhancer-Homer complex couples mGluRI to PI3 kinase, preventing neuronal apoptosis. Nat Neurosci 2003; 6: 1153-61 (Pubitemid 37346035)
4. Ye K, Hurt KJ, Wu FY, Fang M, Luo HR, Hong JJ, et al. Pike. A nuclear gtpase that enhances PI3kinase activity and is regulated by protein .1N. Cell 2000; 103: 919-30
5. Ahn JY, Hu Y, Kroll TG, Allard P, Ye K. PIKE-A is amplified in human cancers and prevents apoptosis by up-regulating Akt. Proc Natl Acad Sci U S A 2004; 101: 6993-8 (Pubitemid 38596431)
6. Elkahloun AG, Krizman DB, Wang Z, Hofmann TA, Roe B, Meltzer PS. Transcript mapping in a 46-kb sequenced region at the core of 12q13.3 amplification in human cancers. Genomics 1997; 42: 295-301 (Pubitemid 27263760)
7. Nagase T, Seki N, Ishikawa K, Tanaka A, Nomura N. Prediction of the coding sequences of unidentified human genes. V. The coding sequences of 40 new genes (KIAA0161-KIAA0200) deduced by analysis of cDNA clones from human cell line KG-1. DNA Res 1996; 3: 17-24 (Pubitemid 126682808)
8. Xia C, Ma W, Stafford LJ, Liu C, Gong L, Martin JF, et al. GGAPs, a new family of bifunctional GTP-binding and GTPase-Activating proteins. Mol Cell Biol 2003; 23: 2476-88 (Pubitemid 36351028)
9. Chan CB, Ye K. PIKE GTPase are phosphoinositide-3-kinase enhancers, suppressing programmed cell death. J Cell Mol Med 2007; 11: 39-53 (Pubitemid 46439624)
10. Liu Z, Jang SW, Liu X, Cheng D, Peng J, Yepes M, et al. Neuroprotective actions of PIKE-L by inhibition of SET proteolytic degradation by asparagine endopeptidase. Mol Cell 2008; 29: 665-78 (Pubitemid 351400928)
11. Tang X, Jang SW, Okada M, Chan CB, Feng Y, Liu Y, et al. Netrin-1 mediates neuronal survival through PIKE-L interaction with the dependence receptor UNC5B. Nat Cell Biol 2008; 10: 698-706 (Pubitemid 351772935)
12. Chan CB, Chen Y, Liu X, Papale L, Escayg A, Mei L, et al. Essential role of PIKE GTPases in neuronal protection against excitotoxic insults. Adv Biol Regul 2011; 52: 66-76
13. Chan CB, Liu X, Pradoldej S, Hao C, An J, Yepes M, et al. Phosphoinositide 3-kinase enhancer regulates neuronal dendritogenesis and survival in neocortex. J Neurosci 2011; 31: 8083-92
14. Chan CB, Liu X, Ensslin MA, Dillehay DL, Ormandy CJ, Sohn P, et al. PIKE-A is required for prolactin-mediated STAT5a activation in mammary gland development. EMBO J 2010; 29: 956-68
15. Chan CB, Liu X, Jung DY, Jun JY, Luo HR, Kim JK, et al. Deficiency of phosphoinositide 3-kinase enhancer protects mice from diet-induced obesity and insulin resistance. Diabetes 2010; 59: 883-93
16. Chan CB, Liu X, He K, Qi Q, Jung DY, Kim JK, et al. The association of phosphoinositide 3-kinase enhancer A with hepatic insulin receptor enhances its kinase activity. EMBO Reports 2011; 12: 847-54
17. Liu X, Hu Y, Hao C, Rempel SA, Ye K. PIKE-A is a proto-oncogene promoting cell growth, transformation and invasion. Oncogene 2007; 26: 4918-27 (Pubitemid 47172641)
18. Adamson ED. Oncogenes in development. Development 1987; 99: 449-71 (Pubitemid 17057490)
19. Weinstein IB, Joe AK. Mechanisms of disease: Oncogene addiction -A rationale for molecular targeting in cancer therapy. Nat Clin Prac 2006; 3: 448-57 (Pubitemid 44203817)
20. Anderson MW, Reynolds SH, You M, Maronpot RM. Role of protooncogene activation in carcinogenesis. Environ Health Perspect 1992; 98: 13-24
21. Putzer BM, Drosten M. The RET proto-oncogene: A potential target for molecular cancer therapy. Trends Mol Med 2004; 10: 351-7 (Pubitemid 38881525)
22. Halpern M. Proto-oncogene products as target antigens for cancer vaccines. Int J Oncol 1997; 11: 863-8 (Pubitemid 27407968)
23. Cai Y, Wang J, Li R, Ayala G, Ittmann M, Liu M. GGAP2/PIKE-A directly activates both the Akt and nuclear factor-kappaB pathways and promotes prostate cancer progression. Cancer Res 2009; 69: 819-27
24. Knobbe CB, Trampe-Kieslich A, Reifenberger G. Genetic alteration and expression of the phosphoinositol-3-kinase/Akt pathway genes PIK3CA and PIKE in human glioblastomas. Neuropathol Appl Neurobiol 2005; 31: 486-90 (Pubitemid 41337782)
25. Xie Z, Jiang Y, Liao EY, Chen Y, Pennypacker SD, Peng J, et al. PIKE mediates EGFR proliferative signaling in squamous cell carcinoma cells. Oncogene 2012; 31: 5090-8
26. Reifenberger G, Ichimura K, Reifenberger J, Elkahloun AG, Meltzer PS, Collins VP. Refined mapping of 12q13-q15 amplicons in human malignant gliomas suggests CDK4/SAS and MDM2 as independent amplification targets. Cancer Res 1996; 56: 5141-5 (Pubitemid 26383027)
27. Reifenberger G, Reifenberger J, Ichimura K, Collins VP. Amplification at 12q13-14 in human malignant gliomas is frequently accompanied by loss of heterozygosity at loci proximal and distal to the amplification site. Cancer Res 1995; 55: 731-4
28. Reifenberger G, Reifenberger J, Ichimura K, Meltzer PS, Collins VP. Amplification of multiple genes from chromosomal region 12q13-14 in human malignant gliomas: Preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS, and MDM2. Cancer Res 1994; 54: 4299-303 (Pubitemid 24273138)
29. Su WT, Alaminos M, Mora J, Cheung NK, La Quaglia MP, Gerald WL. Positional gene expression analysis identifies 12q overexpression and amplification in a subset of neuroblastomas. Cancer Genet Cytogenet 2004; 154: 131-7 (Pubitemid 39345806)
30. Cerami E, Demir E, Schultz N, Taylor BS, Sander C. Automated network analysis identifies core pathways in glioblastoma. PloS one 2010; 5: E8918
31. Wang GX, Poo MM. Requirement of TRPC channels in netrin-1-induced chemotropic turning of nerve growth cones. Nature 2005; 434: 898-904 (Pubitemid 40559002)
32. Ellezam B, Selles-Navarro I, Manitt C, Kennedy TE, McKerracher L. Expression of netrin-1 and its receptors DCC and UNC-5H2 after axotomy and during regeneration of adult rat retinal ganglion cells. Exp Neurol 2001; 168: 105-15 (Pubitemid 32195262)
33. Arakawa H. Netrin-1 and its receptors in tumorigenesis. Nat Rev Cancer 2004; 4: 978-87 (Pubitemid 39626221)
34. Lee HK, Seo IA, Seo E, Seo SY, Lee HJ, Park HT. Netrin-1 induces proliferation of Schwann cells through Unc5b receptor. Biochem Biophys Res Commun 2007; 362: 1057-62 (Pubitemid 47390681)
35. Guenebeaud C, Goldschneider D, Castets M, Guix C, Chazot G, Delloye-Bourgeois C, et al. The dependence receptor UNC5H2/ B triggers apoptosis via PP2A-mediated dephosphorylation of DAP kinase. Mol cell 2012; 40: 863-76
36. Llambi F, Lourenco FC, Gozuacik D, Guix C, Pays L, Del Rio G, et al. The dependence receptor UNC5H2 mediates apoptosis through DAPkinase. EMBO J 2005; 24: 1192-201 (Pubitemid 40516602)
37. Saito YD, Jensen AR, Salgia R, Posadas EM. Fyn: A novel molecular target in cancer. Cancer 2010; 116: 1629-37
38. Mille F, Llambi F, Guix C, Delloye-Bourgeois C, Guenebeaud C, Castro-Obregon S, et al. Interfering with multimerization of netrin-1 receptors triggers tumor cell death. Cell Death Differ 2009; 16: 1344-51
39. He K, Jang SW, Joshi J, Yoo MH, Ye K. Akt-phosphorylated PIKE-A inhibits UNC5B-induced apoptosis in cancer cell lines in a p53-dependent manner. Mol Biol Cell 2011; 22: 1943-54
40. Maeda A, Matsuda F, Goto Y, Cheng Y, Gonda H, Inoue N, et al. Molecular cloning of a porcine (Sus scrofa) apoptosis inhibitory ligand, netrin-1, and its receptor, p53RDL1. J Reprod Dev 2008; 54: 275-80
41. Tanikawa C, Matsuda K, Fukuda S, Nakamura Y, Arakawa H. p53RDL1 regulates p53-dependent apoptosis. Nat Cell Biol 2003; 5: 216-23 (Pubitemid 36322248)
42. Gross JM, Yee D. The type-1 insulin-like growth factor receptor tyrosine kinase and breast cancer: Biology and therapeutic relevance. Cancer Metastasis Rev 2003; 22: 327-36 (Pubitemid 36791890)
43. Hopfner M, Sutter AP, Huether A, Baradari V, Scherubl H. Tyrosine kinase of insulin-like growth factor receptor as target for novel treatment and prevention strategies of colorectal cancer. World J Gastroenterol 2006; 12: 5635-43 (Pubitemid 44594037)
44. Bianchi AB, Hara T, Ramesh V, Gao J, Klein-Szanto AJ, Morin F, et al. Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types. Nat Genet 1994; 6: 185-92 (Pubitemid 24188601)
45. Lasota J, Fetsch JF, Wozniak A, Wasag B, Sciot R, Miettinen M. The neurofibromatosis type 2 gene is mutated in perineurial cell tumors: A molecular genetic study of eight cases. Am J Pathol 2001; 158: 1223-9 (Pubitemid 32281285)
46. Pineau P, Marchio A, Nagamori S, Seki S, Tiollais P, Dejean A. Homozygous deletion scanning in hepatobiliary tumor cell lines reveals alternative pathways for liver carcinogenesis. Hepatology 2003; 37: 852-61 (Pubitemid 36397396)
47. Sheikh HA, Tometsko M, Niehouse L, Aldeeb D, Swalsky P, Finkelstein S, et al. Molecular genotyping of medullary thyroid carcinoma can predict tumor recurrence. Am J Surg Pathol 2004; 28: 101-6 (Pubitemid 38031628)
48. Rong R, Tang X, Gutmann DH, Ye K. Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE-L. Proc Natl Acad Sci U S A 2004; 101: 18200-5 (Pubitemid 40054097)
49. Rui H, Kirken RA, Farrar WL. Activation of receptor-Associated tyrosine kinase JAK2 by prolactin. J Biol Chem 1994; 269: 5364-8 (Pubitemid 24239533)
50. Britschgi A, Andraos R, Brinkhaus H, Klebba I, Romanet V, Muller U, et al. JAK2/STAT5 inhibition circumvents resistance to PI3K/mTOR blockade: A rationale for cotargeting these pathways in metastatic breast cancer. Cancer Cell 2012; 22: 796-811
51. Wagner KU, Rui H. Jak2/Stat5 signaling in mammogenesis, breast cancer initiation and progression. J Mammary Gland Biol Neoplasia 2008; 13: 93-103
52. Liu R, Tian B, Gearing M, Hunter S, Ye K, Mao Z. Cdk5-mediated regulation of the PIKE-A-Akt pathway and glioblastoma cell invasion. Proc Natl Acad Sci U S A 2008; 105: 7570-5 (Pubitemid 351830059)
53. Qi Q, He K, Liu X, Pham C, Meyerkord C, Fu H, et al. Disrupting the PIKE-A/Akt interaction inhibits glioblastoma cell survival, migration, invasion and colony formation. Oncogene 2013; 32: 1030-40
54. Sandilands E, Serrels B, McEwan DG, Morton JP, Macagno JP, McLeod K, et al. Autophagic targeting of Src promotes cancer cell survival following reduced FAK signalling. Nat Cell Biol 2011; 14: 51-60
55. Sawhney RS, Liu W, Brattain MG. A novel role of ERK5 in integrinmediated cell adhesion and motility in cancer cells via Fak signaling. J Cell Physiol 2009; 219: 152-61
56. Van Slambrouck S, Grijelmo C, De Wever O, Bruyneel E, Emami S, Gespach C, et al. Activation of the FAK-src molecular scaffolds and p130Cas-JNK signaling cascades by alpha1-integrins during colon cancer cell invasion. Int J Oncol 2007; 31: 1501-8
57. Zhu Y, Wu Y, Kim JI, Wang Z, Daaka Y, Nie Z. Arf GTPase-Activating protein AGAP2 regulates focal adhesion kinase activity and focal adhesion remodeling. J Biol Chem 2009; 284: 13489-96
58. Sieg DJ, Hauck CR, Schlaepfer DD. Required role of focal adhesion kinase (FAK) for integrin-stimulated cell migration. J Cell Sci 1999; 112: 2677-91 (Pubitemid 29429791)
59. Yeo MG, Sung BH, Oh HJ, Park ZY, Marcantonio EE, Song WK. Focal adhesion targeting of v-Crk is essential for FAK phosphorylation and cell migration in mouse embryo fibroblasts deficient src family kinases or p130CAS. J Cell Physiol 2008; 214: 604-13 (Pubitemid 351224204)
60. Xie Z, Sanada K, Samuels BA, Shih H, Tsai LH. Serine 732 phosphorylation of FAK by Cdk5 is important for microtubule organization, nuclear movement, and neuronal migration. Cell 2003; 114: 469-82 (Pubitemid 37100995)
61. Ilic D, Damsky CH, Yamamoto T. Focal adhesion kinase: At the crossroads of signal transduction. J Cell Sci 1997; 110 (Pt 4): 401-7 (Pubitemid 27116721)
62. Martelli AM, Evangelist C, Billi AM, Manzoli L, Papa V, Cocco L. Intranuclear 3′-phosphoinositide metabolism and apoptosis protection in PC12 cells. Acta Biomed 2007; 78: 113-9
63. Martelli AM, Faenza I, Billi AM, Manzoli L, Evangelisti C, Fala F, et al. Intranuclear 3′-phosphoinositide metabolism and Akt signaling: New mechanisms for tumorigenesis and protection against apoptosis? Cell Signal 2006; 18: 1101-7 (Pubitemid 43674029)
64. Matteucci A, Faenza I, Gilmour RS, Manzoli L, Billi AM, Peruzzi D, et al. Nuclear but not cytoplasmic phospholipase C beta 1 inhibits differentiation of erythroleukemia cells. Cancer Res 1998; 58: 5057-60 (Pubitemid 28521160)
65. York JD, Majerus PW. Nuclear phosphatidylinositols decrease during S-phase of the cell cycle in HeLa cells. J Biol Chem 1994; 269: 7847-50 (Pubitemid 24200178)
66. Wang Z, Gluck S, Zhang L, Moran MF. Requirement for phospholipase C-gamma1 enzymatic activity in growth factor-induced mitogenesis. Mol Cell Biol 1998; 18: 590-7 (Pubitemid 28021069)
67. Diakonova M, Chilov D, Arnaoutov A, Alexeyev V, Nikolsky N, Medvedeva N. Intracellular distribution of phospholipase C gamma 1 in cell lines with different levels of transformation. Eur J Cell Biol 1997; 73: 360-7 (Pubitemid 27370892)
68. Neri LM, Borgatti P, Capitani S, Martelli AM. Nuclear diacylglycerol produced by phosphoinositide-specific phospholipase C is responsible for nuclear translocation of protein kinase C-Alpha. J Biol Chem 1998; 273: 29738-44 (Pubitemid 28509985)
69. Ye K, Snyder SH. PIKE GTPase: A novel mediator of phosphoinositide signaling. J Cell Sci 2004; 117 (Pt 2): 155-61 (Pubitemid 38128896)
70. Kim H, Huang W, Jiang X, Pennicooke B, Park PJ, Johnson MD. Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship. Proc Natl Acad Sci U S A 2010; 107: 2183-8
71. Xie Z, Chen Y, Liao EY, Jiang Y, Liu FY, Pennypacker SD. Phospholipase C-gamma1 is required for the epidermal growth factor receptorinduced squamous cell carcinoma cell mitogenesis. Biochem Biophys Res Commun 2010; 397: 296-300
72. Xie Z, Chen Y, Pennypacker SD, Zhou Z, Peng D. The SH3 domain, but not the catalytic domain, is required for phospholipase C-gamma1 to mediate epidermal growth factor-induced mitogenesis. Biochem Biophys Res Commun 2010; 398: 719-22
73. Ye K, Aghdasi B, Luo HR, Moriarity JL, Wu FY, Hong JJ, et al. Phospholipase C gamma 1 is a physiological guanine nucleotide exchange factor for the nuclear GTPase PIKE. Nature 2002; 415: 541-4 (Pubitemid 34130610)
74. Niemann HH, Knetsch ML, Scherer A, Manstein DJ, Kull FJ. Crystal structure of a dynamin GTPase domain in both nucleotide-free and GDP-bound forms. EMBO J 2001; 20: 5813-21 (Pubitemid 33049257)
75. Razidlo GL, Wang Y, Chen J, Krueger EW, Billadeau DD, McNiven MA. Dynamin 2 potentiates invasive migration of pancreatic tumor cells through stabilization of the Rac1 GEF Vav1. Dev Cell 2013; 24: 573-85
76. Lopez-Haber C, Kazanietz MG. Cucurbitacin I inhibits rac1 activation in breast cancer cells by a reactive oxygen species-mediated mechanism and independently of janus tyrosine kinase 2 and p-rex1. Mol Pharmacol 2013; 83: 1141-54
77. Lemmon MA. Pleckstrin homology (PH) domains and phosphoinositides. Biochem Soc Symp 2007; (74): 81-93
78. Hu Y, Liu Z, Ye K. Phosphoinositol lipids bind to phosphatidylinositol 3 (PI3)-kinase enhancer GTPase and mediate its stimulatory effect on PI3-kinase and Akt signalings. Proc Natl Acad Sci U S A 2005; 102: 16853-8 (Pubitemid 41688866)
79. Yan J, Wen W, Chan LN, Zhang M. Split pleckstrin homology domainmediated cytoplasmic-nuclear localization of PI3-kinase enhancer GTPase. J Mol Biol 2008; 378: 425-35
80. Lehman HL, Van Laere SJ, van Golen CM, Vermeulen PB, Dirix LY, van Golen KL. Regulation of inflammatory breast cancer cell invasion through Akt1/PKBalpha phosphorylation of RhoC GTPase. Mol Cancer Res 2012; 10: 1306-18
81. Tang X, Feng Y, Ye K. Src-family tyrosine kinase fyn phosphorylates phosphatidylinositol 3-kinase enhancer-Activating Akt, preventing its apoptotic cleavage and promoting cell survival. Cell Death Differ 2007; 14: 368-77 (Pubitemid 46092239)
82. Tang X, Ye K. Pike tyrosine phosphorylation regulates its apoptotic cleavage during programmed cell death. Adv Enzyme Regul 2006; 46: 289-300 (Pubitemid 44301364)
83. Yadav V, Denning MF. Fyn is induced by Ras/PI3K/Akt signaling and is required for enhanced invasion/migration. Mol Carcinog 2011; 50: 346-52
84. Sanz-Pamplona R, Berenguer A, Sole X, Cordero D, Crous-Bou M, Serra-Musach J, et al. Tools for protein-protein interaction network analysis in cancer research. Clin Transl Oncol 2012; 14: 3-14
85. Jameson KL, Mazur PK, Zehnder AM, Zhang J, Zarnegar B, Sage J, et al. IQGAP1 scaffold-kinase interaction blockade selectively targets RAS-MAP kinase-driven tumors. Nat Med 2013; 19:626-30
86. Montalvo-Ortiz BL, Castillo-Pichardo L, Hernandez E, Humphries-Bickley T, De la Mota-Peynado A, Cubano LA, et al. Characterization of EHop-016, novel small molecule inhibitor of Rac GTPase. J Biol Chem 2012; 287: 13228-38
87. De Las Rivas J, Fontanillo C. Protein-protein interaction networks: Unraveling the wiring of molecular machines within the cell. Brief Funct Genomics 2012; 11: 489-96
88. Watanabe N, Osada H. Phosphorylation-dependent protein-protein interaction modules as potential molecular targets for cancer therapy. Curr Drug Targets 2012; 13: 1654-8
89. Navankasattusas S, Whitehead KJ, Suli A, Sorensen LK, Lim AH, Zhao J, et al. The netrin receptor UNC5B promotes angiogenesis in specific vascular beds. Development 2008; 135: 659-67 (Pubitemid 351405019)
90. Hardie DG. The LKB1-AMPK pathway-friend or Foe in cancer? Cancer Cell 2013; 23: 131-2